Trombopag 25 Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Eltrombopag (25mg)
Overview Trombopag 25 Tablet
Trombopag 25mg tablets are indicated for the management of thrombocytopenia stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV). This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, trombopag stimulates platelet production, thus mitigating bleeding risks. Adhere strictly to your physician's prescribed dosage and regimen. Administration may occur on an empty stomach; swallow the tablet whole—avoid crushing, chewing, or breaking. Report any allergies to this medication to your doctor. Common adverse reactions encompass nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Should these side effects prove troublesome, consult your physician for potential mitigation strategies. Prior to commencing treatment, disclose any existing health issues and all concurrent medications. Hepatic impairment may necessitate dosage modifications, requiring consultation with your doctor.
Uses of Trombopag 25 Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; managing critical aplastic anemia.
Major Benefits of Trombopag 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trombopag 25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
Common Side effects of Trombopag 25 Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Trombopag 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trombopag 25 Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
How Trombopag 25 Tablet works:
Each Trombopag 25 mg tablet functions as a thrombopoietin receptor activator, boosting platelet production within the bloodstream. This increase in platelets aids in minimizing or averting hemorrhaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Trombopag 25 Tablet may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Use of Trombopag 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Trombopag 25mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Trombopag 25 Tablet due to potential side effects such as dizziness and reduced alertness. These side effects can negatively impact your capacity to drive safely.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Trombopag 25 Tablet without a recommended dosage change. Nevertheless, kidney disease should be disclosed to your physician. Routine monitoring of kidney function is suggested during treatment.
LiverCAUTION
Patients with liver impairment should use Trombopag 25 mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Trombopag 25 Tablet :
Omit any missed Trombopag 25 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Trombopag 25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin stimulator |
3,018 People bought this recently
